Sophia Genetics and Element Biosciences partner in genomic workflow streamlining

Sophia Genetics (SOPH) and Element Biosciences, a biology company, announced at the Association for Molecular Pathology Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting precision medicine. This collaboration integrates Sophia Genetics’ AI-powered analytics platform, SOPHiA DDM, with Element’s AVITI24 5D multiomic and AVITI sequencing systems to deliver end-to-end workflow for next-generation sequencing. Together, the technologies will provide speed, scalability, and flexibility, enabling clinical researchers to turn NGS data into actionable insights within a single streamlined process. AVITI and AVITI24 users will also gain access to the full suite of SOPHiA DDM applications in oncology and rare disease, expanding the analytical power of their sequencing workflows.